Computer-guided microwave ablation for liver cancer
Part of Cancer, Digestive system clinical trials.
This study tests a computer-guided microwave ablation procedure to destroy liver tumors. If you have early-stage liver cancer with up to 5 tumors, and one is 2-5 cm in size, you may be a candidate.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and expected to live at least 1 more year.
- You have liver cancer (HCC) confirmed by imaging, biopsy, or high AFP levels.
- You have no more than 5 liver tumors, with all tumors 5 cm or smaller and at least one tumor between 2 and 5 cm.
- The cancer has not spread into major blood vessels or outside the liver.
- You are physically active enough to care for yourself (ECOG score 0-2).
- You have adequate blood clotting function (platelets at least 50,000 and INR 1.8 or lower, or correctable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of microwave ablation (a heat-based treatment that destroys tumors) with standard surgery for liver cancer tumors that sit near the surface of the liver. The goal is to see which treatment is safer and works better for people whose tumors are close to the liver's outer edge.
This study uses advanced imaging (MRI and contrast-enhanced ultrasound) with computer technology to help doctors decide the best treatment for early-stage liver cancer. It aims to improve outcomes for patients who undergo surgery or microwave ablation.
This study tests whether using a special technique (diaphragm hydrodissection) during microwave ablation—a treatment that uses heat to destroy cancer cells—can effectively treat liver cancer located near the diaphragm. It compares this approach to standard surgery, aiming to find a safer or less invasive option.
This trial tests a new type of treatment using low-energy radio waves (called electromagnetic fields) for people with advanced liver cancer that can't be removed by surgery. The goal is to see if adding this therapy can help your immune system fight the cancer better.
This trial compares two ways to treat hepatocellular carcinoma (a type of liver cancer): microwave ablation and laparoscopic hepatectomy (keyhole liver surgery). It may help find which option works better for tumor control and recovery in people with limited, non-spread cancer.
This study tests a microwave ablation device to destroy small liver tumors (up to 4 cm) using heat, without major surgery. It is designed for patients with limited disease (1 or 2 tumors) and good liver function.
Hear when a new Hepatocellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.